AXSOME THERAPEUTICS, INC. (AXSM) Operating income 2016–2025
AXSOME THERAPEUTICS, INC. (AXSM) annual operating income history from SEC filings — each fiscal year as reported.
-$166.8MFY2025 · since FY2016: -$27.5M → -$166.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$166.8M | +40.6% |
| FY2024 | -$280.6M | -21.0% |
| FY2023 | -$231.8M | -28.9% |
| FY2022 | -$179.8M | -44.2% |
| FY2021 | -$124.7M | -25.8% |
| FY2020 | -$99.1M | -47.4% |
| FY2019 | -$67.2M | -104.7% |
| FY2018 | -$32.8M | -20.9% |
| FY2017 | -$27.2M | +1.4% |
| FY2016 | -$27.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice